The ticker symbol ORGO represents the common equity shares of Organogenesis Holdings Inc., which are traded publicly on the NASDAQ stock exchange. Investors purchase and sell ORGO stock to gain financial exposure to the advanced medical technology and regenerative medicine sector, tracking corporate revenue growth from bio-active wound care products, clinical trial milestones, gross margin expansions, and broader biotechnology market trends.